Serina Therapeutics, Inc. - 10-Q Filing
Serina Therapeutics reports Q3 2026 financial results including details on Roth Committed Equity Facility and merger-related warrant activity.
Tickers: $SER
More Regulatory news
- FACT II Acquisition Corp. - 10-Q Filing
- Marblegate Capital Corp - 10-Q Filing
- Greenland Mines Ltd - 8-K Filing
- InspireMD, Inc. - 8-K Filing
- InspireMD, Inc. - 8-K Filing
- Pinnacle Acquisition Corp - 10-Q Filing
- SUTRO BIOPHARMA, INC. - 8-K Filing
- Aeluma, Inc. - 8-K Filing
- ASTEC INDUSTRIES INC - 8-K Filing
- Live Oak Bancshares, Inc. - 8-K Filing